These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The cure of Hodgkin's disease with drugs. DeVita VT, Hubbard SM, Moxley JH. Adv Intern Med; 1983 Jan; 28():277-302. PubMed ID: 6188346 [No Abstract] [Full Text] [Related]
3. More than MOPP for advanced Hodgkin's disease? Mayer RJ. N Engl J Med; 1982 Apr 01; 306(13):800-2. PubMed ID: 6174866 [No Abstract] [Full Text] [Related]
4. Combination chemotherapy in stages I or II Hodgkin's disease. Lauria F, Baccarani M, Fiaccini M, Mazza P, Tura S. Lancet; 1979 Nov 17; 2(8151):1072-3. PubMed ID: 91806 [No Abstract] [Full Text] [Related]
5. Alternating drug combinations for advanced Hodgkin's disease. N Engl J Med; 1982 Sep 09; 307(11):687-9. PubMed ID: 6180317 [No Abstract] [Full Text] [Related]
6. Hodgkin's disease: combination chemotherapy for relapse following radical radiotherapy. Timothy AR, Sutcliffe SB, Wrigley PF, Jones AE. Int J Radiat Oncol Biol Phys; 1979 Feb 09; 5(2):165-9. PubMed ID: 457468 [No Abstract] [Full Text] [Related]
7. ChlVPP/PABlOE and radiotherapy in advanced Hodgkin's disease. The Central Lymphoma Group. Cullen MH, Stuart NS, Woodroffe C, Murphy A, Fletcher J, Blackledge GR, Child JA, Grieve RJ, Jones EL. J Clin Oncol; 1994 Apr 09; 12(4):779-87. PubMed ID: 7512132 [Abstract] [Full Text] [Related]
8. Chemotherapy in the treatment of Hodgkin's disease. Canellos GP, Come SE, Skarin AT. Semin Hematol; 1983 Jan 09; 20(1):1-24. PubMed ID: 6189191 [No Abstract] [Full Text] [Related]
9. [Advances in the chemotherapy of malignant lymphoma 1. Chemotherapy of Hodgkin's disease]. Suon SZ. Zhonghua Nei Ke Za Zhi; 1985 Feb 09; 24(2):117-120, contd. PubMed ID: 2580675 [No Abstract] [Full Text] [Related]
10. Pregnancy after chemotherapy for Hodgkin's disease. Johnson SA, Goldman JM, Hawkins DF. Lancet; 1979 Jul 14; 2(8133):93. PubMed ID: 87982 [No Abstract] [Full Text] [Related]
11. [Treatment maintaining complete remission in Hodgkin's disease]. Armata J. Pol Tyg Lek; 1981 Feb 23; 36(8):301-4. PubMed ID: 7022410 [No Abstract] [Full Text] [Related]
12. Adriamycin, bleomycin, vinblastine and imidazole carboxamide (ABVD) therapy for advanced Hodgkin's disease resistant to mustine, vinblastine, procarbazine and prednisolone (MVPP). Sutcliffe SB, Wrigley PF, Stansfeld AG, Malpas JS. Cancer Chemother Pharmacol; 1979 Feb 23; 2(3):209-13. PubMed ID: 88280 [Abstract] [Full Text] [Related]
13. Towards curative treatment of advanced Hodgkin's disease. Falkson HC, Falkson G. S Afr Med J; 1975 Sep 06; 49(38):1545-9. PubMed ID: 1179225 [Abstract] [Full Text] [Related]
14. Chemotherapy of Hodgkin's disease in studies by acute leukemia group B. Nissen NI, Stutzman L, Holland JF, Glidewell OJ. Arch Intern Med; 1973 Mar 06; 131(3):396-401. PubMed ID: 4688038 [No Abstract] [Full Text] [Related]
15. The cure of disseminated Hodgkin's disease: prospects and problems. Streuli RA, Ultmann JE. Ann Intern Med; 1980 May 06; 92(5):693-5. PubMed ID: 7387012 [No Abstract] [Full Text] [Related]
16. [Function of the lungs in patients with Hodgkin's disease after chemotherapy and radiotherapy]. Milanowski A, Kulus M, Matysiak M, Ochocka M. Pediatr Pol; 1988 Nov 06; 63(11):747-52. PubMed ID: 2473435 [No Abstract] [Full Text] [Related]
17. Combination chemotherapy in advanced and recurrent Hodgkin's disease. McElwain TJ, Wrigley PF, Hunter A, Crowther D, Malpas JS, Peckham MJ, Smithers DW, Fairley GH. Natl Cancer Inst Monogr; 1973 May 06; 36():395-402. PubMed ID: 4744597 [No Abstract] [Full Text] [Related]
18. [Treatment outcome of advanced Hodgkin's disease based on using an alternating program ChLVPP (chlorambucil, vinblastine, procarbazine, prednisone) and ABV (doxorubicin, bleomycin, vinblastine)]. Komarnicki M, Balcerzak A, Górski P, Pawlak L, Hansz J. Acta Haematol Pol; 1994 May 06; 25(4):363-8. PubMed ID: 7531381 [Abstract] [Full Text] [Related]
19. Prognosis of Hodgkin's disease: patients who fail to remit or who relapse after combination chemotherapy. Sutcliffe SB, Economopoulos T, Wrigley PF, Stansfeld AG, Malpas JS. Clin Oncol; 1980 Dec 06; 6(4):329-36. PubMed ID: 6161731 [No Abstract] [Full Text] [Related]
20. Three years' experience with Ch1VPP (a combination of drugs of low toxicity) for the treatment of Hodgkin's disease. Kaye SB, Juttner CA, Smith IE, Barrett A, Austin DE, Peckham MJ, McElwain TJ. Br J Cancer; 1979 Feb 06; 39(2):168-74. PubMed ID: 435366 [Abstract] [Full Text] [Related] Page: [Next] [New Search]